17762 | $CMPI On Alert! Checkmate Pharmaceuticals to | jmtimz | 06/08/2021 8:33:06 AM |
19587 | $CBDD A key driver of the Company's year-to-date | Lets Roll | 12/21/2021 10:01:59 AM |
4442 | $IMLFF InMed Pharma Appoints Eli Lilly Finance | budfoxfun | 01/30/2017 8:33:13 AM |
4441 | $BFGC Bullfrog Gold Corp Should Be on Your Focus | budfoxfun | 01/30/2017 8:33:04 AM |
4440 | $OBMP Latest Clinical Data from OncBioMune | budfoxfun | 01/30/2017 8:32:52 AM |
4439 | $SHOM Dr. Liu Zongzheng's Patent Technology to | budfoxfun | 01/30/2017 8:32:42 AM |
4438 | $MRPHF otcqb stock on alert this week! | budfoxfun | 01/30/2017 8:32:29 AM |
4437 | $SING software solutions are specifically | Lets Roll | 01/30/2017 6:25:09 AM |
4436 | $ETST Take a look at the informative company | Lets Roll | 01/30/2017 5:50:32 AM |
4435 | Renewed Investor Interest in SMS Marketing, like | makebucks | 01/30/2017 2:10:50 AM |
4434 | BSSP | budfoxfun | 01/30/2017 12:28:16 AM |
4433 | WDRP | budfoxfun | 01/30/2017 12:27:46 AM |
4432 | VGID | budfoxfun | 01/30/2017 12:27:36 AM |
4431 | USMJ | budfoxfun | 01/30/2017 12:27:19 AM |
4430 | UNGS | budfoxfun | 01/30/2017 12:27:03 AM |
4429 | UAMM | budfoxfun | 01/30/2017 12:26:51 AM |
4428 | TXTM | budfoxfun | 01/30/2017 12:26:40 AM |
4427 | TTCM | budfoxfun | 01/30/2017 12:26:31 AM |
4426 | THC | budfoxfun | 01/30/2017 12:26:18 AM |
4425 | TALK | budfoxfun | 01/30/2017 12:26:09 AM |
4424 | SVTE | budfoxfun | 01/30/2017 12:25:53 AM |
4423 | SPCL | budfoxfun | 01/30/2017 12:25:37 AM |
4422 | SOUM | budfoxfun | 01/30/2017 12:24:56 AM |
4421 | SIPC | budfoxfun | 01/30/2017 12:24:44 AM |
4420 | SGBY | budfoxfun | 01/30/2017 12:22:16 AM |
4419 | FOR | budfoxfun | 01/30/2017 12:22:04 AM |
4418 | SDVI S | budfoxfun | 01/30/2017 12:21:52 AM |
4417 | RUN | budfoxfun | 01/30/2017 12:21:41 AM |
4416 | RJDG | budfoxfun | 01/30/2017 12:21:31 AM |
4415 | RDAR | budfoxfun | 01/30/2017 12:21:24 AM |
4414 | POST | budfoxfun | 01/30/2017 12:21:13 AM |
4413 | PMCB | budfoxfun | 01/30/2017 12:21:03 AM |
4412 | PLPL | budfoxfun | 01/30/2017 12:20:54 AM |
4411 | PLAY | budfoxfun | 01/30/2017 12:20:44 AM |
4410 | OWCP | budfoxfun | 01/30/2017 12:20:31 AM |
4409 | ORRV | budfoxfun | 01/30/2017 12:20:19 AM |
4408 | NOUV | budfoxfun | 01/30/2017 12:20:06 AM |
4407 | MJTK | budfoxfun | 01/30/2017 12:19:58 AM |
4406 | MJMJ | budfoxfun | 01/30/2017 12:19:51 AM |
4405 | MFST | budfoxfun | 01/30/2017 12:19:42 AM |
4404 | LUVU | budfoxfun | 01/30/2017 12:19:32 AM |
4403 | ISBG | budfoxfun | 01/30/2017 12:19:23 AM |
4402 | ICNB | budfoxfun | 01/30/2017 12:19:13 AM |
4401 | HWAL | budfoxfun | 01/30/2017 12:18:50 AM |
4400 | HIRU | budfoxfun | 01/30/2017 12:18:34 AM |
4399 | HAS | budfoxfun | 01/30/2017 12:18:21 AM |
4398 | GRPOF | budfoxfun | 01/30/2017 12:18:12 AM |
4397 | GMNI | budfoxfun | 01/30/2017 12:18:01 AM |
4396 | EQLB | budfoxfun | 01/30/2017 12:17:53 AM |
4395 | EEGI | budfoxfun | 01/30/2017 12:17:46 AM |
4394 | DRYS | budfoxfun | 01/30/2017 12:17:36 AM |
4393 | DRNK | budfoxfun | 01/30/2017 12:17:26 AM |
Recent Articles
- Devin Nunes Celebrates Victory for Free Speech Against Censorship
- HBM Alpha Therapeutics Partners for Groundbreaking CRH Therapies
- Devin Nunes Celebrates Victory for Free Speech Regarding Rumble
- Investigation Launched: DISA Global Solutions Data Breach
- Clorox Enhances Shareholder Value with Regular Dividend Pay
- Jewelry Designer Danielle Nicole Enright's Inspiring Journey
- Selena Gomez and Benny Blanco's Luxurious Beverly Hills Purchase
- Goodwin Appoints Aviation Expert Rich Brennan to Lead Sales Team
- Charter Communications' CEO to Present at Major Conference
- HBM Alpha Therapeutics Partners to Advance Innovative Therapies
- Telix Pharmaceuticals Receives FDA Priority Review for Zircaix
- NACG Declares Quarterly Dividend to Support Shareholder Value
- Danielle Lee-Hogervorst's Journey to Broadway Stardom
- Data Breach at DISA Global Solutions Raises Security Concerns
- NACG Declares Quarterly Dividend for Shareholders
- Discover the Innovative Preamble Collection by Classic Homes
- Telefônica Brasil Reports Impressive 4Q24 Earnings Growth
- Investors Navigate Securities Issues with Maravai LifeSciences
- Exploring Innovations in Animal Health at WVC Conference 2025
- Rumble's Landmark Court Victory Against Foreign Censorship
- Legal Options for FMC Shareholders Facing Significant Losses
- Ultralife Corporation's Delay in Fourth Quarter Reporting
- FTI Consulting Welcomes New Leaders to Enhance Asia Services
- Investor Action for Monolithic Power Systems Before Deadline
- Mesoblast Limited Updates on Financial Results and Growth Plans
- The Growth of Gold Fields Ltd: A 5-Year Investment Journey
- Bill Ackman's Ambitious $90 Offer: Aiming for a Trillion Dollar Future
- Investment Insights: Growth of $1000 in Advanced Micro Devices
- Transforming a $1000 Investment in UnitedHealth Over Two Decades
- Atkore Inc. Class Action Lawsuit: What Investors Need to Know
- Regeneron Pharmaceuticals Faces Class Action Over Eylea Sales
- Classic Homes Introduces the Sustainable Preamble Collection
- QYOU Media’s Upcoming Shareholder Call and New Developments
- Stay Informed: Lawsuit Against Intellia Therapeutics Update
- AURORRA By ARRIS Carbon Fiber Insoles Earn APMA Seal of Acceptance
- STAK Inc. Sets the Stage for Upcoming Initial Public Offering
- Ultralife Corporation's Upcoming Fourth Quarter Earnings
- FTI Consulting Strengthens Leadership in Asia's Forensic Sector
- Mesoblast's Operational Highlights and Financial Insights Unveiled
- MediaTek Unveils M90 5G-Advanced Modem with Incredible Features
- 5N Plus Inc. Achieves Impressive Revenue Growth in 2024
- ZoomInfo Technologies Reports Impressive Q4 Earnings and Outlook
- Important Update: Class Action Lawsuit Against GSK plc
- Legal Update: Class Action Lawsuit for Monolithic Power Systems
- MediaTek Unveils the M90: Revolutionizing 5G Connectivity
- Investigation into Huntington Ingalls Claims: What You Need to Know
- Recent Investigations into Avis Budget Group, Inc. Securities Issues
- Neumora Therapeutics Faces Class Action Investors Should Know
- Investors Urged to Act: Class Action for Intellia Therapeutics
- Investigation Launched into Potential Securities Fraud by Olin Corporation